Psychometric Properties of the Japanese Version of the EQ-5D-Y by Self-report and Proxy-report: Reliability and Construct Validity

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2019 Jun 28

PMID 31243620

Citations 23

Authors

T Shiroiwa

T Fukuda

K Shimozuma

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aimed to assess psychometric properties of the Japanese version of the EQ-5D-Y (3 levels) with a focus on feasibility, reliability, and construct validity.

Methods: Respondents were recruited from the general populations of three cities in Japan. First, children and adolescents responded to the EQ-5D-Y and PedsQL by self-report. Parents were also asked to evaluate the health states of their children/adolescents using proxy versions of these questionnaires. Next, the EQ-5D-Y was mailed to their residence approximately 2 weeks later, and both children/adolescents and their parents responded to the questionnaire. Reliability was confirmed by self-report test-retest methods and a comparison of self-report responses with proxy responses. Spearman's correlation coefficients were calculated between responses to the EQ-5D-Y and both responses to and scores of the PedsQL in order to assess construct validity.

Results: A total of 654 children/adolescents from aged 8 to 15 (median age: 11) responded to the questionnaires at both the first- and second-stage surveys. Test-retest agreement was sufficiently high and was influenced by age. Proxy test-retest results revealed that parents' responses were more reliable compared to the self-report results. Some correlations (|r| > 0.3) between items of the EQ-5D-Y and PedsQL were found. Meanwhile, no correlations were found between proxy responses to the EQ-5D-Y and self-report responses to the PedsQL.

Conclusions: The EQ-5D-Y demonstrates reliability and validity among children/adolescents and their parents in Japan. Construct validity of the EQ-5D-Y by self-report was confirmed through comparisons with the PedsQL. Proxy responses to the EQ-5D-Y were more reliable compared to the self-report results, but construct validity was not confirmed in the proxy version.

Citing Articles

How does a preference-based generic health-related quality of life measure perform in patients with a rare disease? Measurement properties of the EQ-5D-Y proxy version among underage patients with neurofibromatosis type 1.

Liang W, Cao S, Suo Y, Zhang L, Yang L, Wang H Orphanet J Rare Dis. 2025; 20(1):71.

PMID: 39948669 PMC: 11827137. DOI: 10.1186/s13023-025-03590-x.

Differential seasonal performance of C3-epi-D3 level and proportion on multiple metabolic disorders in patients with type 2 diabetes mellitus.

Chen X, Peng B, Ye W, Wu B, Yang Q, Tang J Eur J Med Res. 2024; 29(1):617.

PMID: 39710722 PMC: 11665098. DOI: 10.1186/s40001-024-02212-9.

Long-term distress throughout one's life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China.

Liang W, Cao S, Suo Y, Zhang L, Yang L, Wang P Front Public Health. 2024; 12:1398803.

PMID: 39234078 PMC: 11371622. DOI: 10.3389/fpubh.2024.1398803.

Validation of the EQ-5D-Y-5L parent-proxy version among children with juvenile idiopathic arthritis.

Ohinmaa A, Wen J, Currie G, Benseler S, Swart J, Vastert S Qual Life Res. 2024; 33(10):2677-2691.

PMID: 39141175 PMC: 11452410. DOI: 10.1007/s11136-024-03682-4.

Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19.

Zhou W, Li Y, Busschbach J, Herdman M, Yang Z, Lu Y Eur J Health Econ. 2024; .

PMID: 39066840 DOI: 10.1007/s10198-024-01710-1.

References

Torrance G, Feeny D, Furlong W, Barr R, Zhang Y, Wang Q . Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care. 1996; 34(7):702-22. DOI: 10.1097/00005650-199607000-00004. View

Landgraf J, Maunsell E, Speechley K, Bullinger M, Campbell S, Abetz L . Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results. Qual Life Res. 1998; 7(5):433-45. DOI: 10.1023/a:1008810004694. View

Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burstrom K, Cavrini G . Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010; 19(6):887-97. PMC: 2892614. DOI: 10.1007/s11136-010-9649-x. View

Shafie A, Hassali M, Liau S . A cross-sectional validation study of EQ-5D among the Malaysian adult population. Qual Life Res. 2010; 20(4):593-600. DOI: 10.1007/s11136-010-9774-6. View

Ravens-Sieberer U, Gosch A, Rajmil L, Erhart M, Bruil J, Duer W . KIDSCREEN-52 quality-of-life measure for children and adolescents. Expert Rev Pharmacoecon Outcomes Res. 2009; 5(3):353-64. DOI: 10.1586/14737167.5.3.353. View

Mokkink L, Terwee C, Patrick D, Alonso J, Stratford P, Knol D . The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010; 19(4):539-49. PMC: 2852520. DOI: 10.1007/s11136-010-9606-8. View

Kontodimopoulos N, Pappa E, Niakas D, Yfantopoulos J, Dimitrakaki C, Tountas Y . Validity of the EuroQoL (EQ-5D) instrument in a Greek general population. Value Health. 2008; 11(7):1162-9. DOI: 10.1111/j.1524-4733.2008.00356.x. View

Devlin N, Shah K, Feng Y, Mulhern B, van Hout B . Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2017; 27(1):7-22. PMC: 6680214. DOI: 10.1002/hec.3564. View

Brauer C, Rosen A, Greenberg D, Neumann P . Trends in the measurement of health utilities in published cost-utility analyses. Value Health. 2006; 9(4):213-8. DOI: 10.1111/j.1524-4733.2006.00116.x. View

10.

Kharroubi S, Brazier J, Roberts J, OHagan A . Modelling SF-6D health state preference data using a nonparametric Bayesian method. J Health Econ. 2006; 26(3):597-612. DOI: 10.1016/j.jhealeco.2006.09.002. View

11.

Shiroiwa T, Ikeda S, Noto S, Igarashi A, Fukuda T, Saito S . Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. Value Health. 2016; 19(5):648-54. DOI: 10.1016/j.jval.2016.03.1834. View

12.

Matza L, Secnik K, Mannix S, Sallee F . Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK. Pharmacoeconomics. 2005; 23(8):777-90. DOI: 10.2165/00019053-200523080-00004. View

13.

Kreimeier S, Greiner W . EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument's Characteristics, Development, Current Use, and Challenges of Developing Its Value Set. Value Health. 2019; 22(1):31-37. DOI: 10.1016/j.jval.2018.11.001. View

14.

Brooks R . EuroQol: the current state of play. Health Policy. 1996; 37(1):53-72. DOI: 10.1016/0168-8510(96)00822-6. View

15.

Badia X, Schiaffino A, Alonso J, Herdman M . Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. Qual Life Res. 1998; 7(4):311-22. DOI: 10.1023/a:1024933913698. View

16.

Rabin R, de Charro F . EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001; 33(5):337-43. DOI: 10.3109/07853890109002087. View

17.

Varni J, Seid M, Rode C . The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999; 37(2):126-39. DOI: 10.1097/00005650-199902000-00003. View

18.

Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011; 20(10):1727-36. PMC: 3220807. DOI: 10.1007/s11136-011-9903-x. View

19.

van Hout B, Janssen M, Feng Y, Kohlmann T, Busschbach J, Golicki D . Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012; 15(5):708-15. DOI: 10.1016/j.jval.2012.02.008. View

20.

Kim T, Jo M, Lee S, Kim S, Chung S . Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res. 2012; 22(8):2245-53. DOI: 10.1007/s11136-012-0331-3. View